Aclaris Therapeutics, Inc. · NASDAQ:ACRS
Aclaris Therapeutics, Inc. shareholders
As of Sep 30, 2026, 161 institutions reported holding Aclaris Therapeutics, Inc., 87.3% of its shares. Largest: Ra Capital Management, L.P., BML Capital Management, LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aclaris Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 12.7M | 8.0% | no change | Nov 16, 2026 |
| BML Capital Management, LLC | 11M | 6.9% | −1.02M | Nov 6, 2026 |
| BlackRock | 10.4M | 6.5% | +340K | Nov 13, 2026 |
| Deep Track Capital, LP | 9.35M | 5.9% | no change | Nov 16, 2026 |
| Frazier Life Sciences Management, L.P. | 8.73M | 5.5% | +3.8M | Nov 16, 2026 |
| Vanguard | 8.37M | 5.3% | +31,909 | Nov 16, 2026 |
| Fidelity | 7.05M | 4.4% | +6.73M | Nov 10, 2026 |
| Vivo Capital, LLC | 6.69M | 4.2% | no change | Nov 13, 2026 |
| Mpm Bioimpact LLC | 5.18M | 3.3% | +4.14M | Nov 16, 2026 |
| Decheng Capital LLC | 4.04M | 2.5% | no change | Nov 13, 2026 |